Serial Number
99001102
Owner
Absco Therapeutics, Inc.Attorney
Susan Neuberger WellerFiling Date
Jan 16, 2025
ABSCOTX Trademark
Serial Number: 99001102
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
Susan Neuberger Weller Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
555 12th Street NW
Suite 1100
Washington, DC 20004
United States
Trademark Details
Filing Date
January 16, 2025
Registration Date
Not Registered
Published for Opposition
August 19, 2025
Goods & Services
Pharmaceutical preparations and pharmaceutical products for the treatment of cancer; imaging agents for monitoring cancer treatments; immunotherapy pharmaceutical preparations for the treatment of cancer consisting of image guided therapy injections into tumors to educate the immune system to fight cancer and modify the tumor environment to fight cancer cells
Medical and therapeutic services, namely, immunotherapy services for the treatment of cancer; Medical imaging services for use in cancer treatment
Medical instruments which use an imaging agent for use in delivery of immunotherapy cancer treatments; Medical imaging apparatus
Scientific and medical research in the field of oncology and gynecology; research and development of pharmaceuticals for the treatment of cancer; immunological analyses for scientific research and medical research; Medical research in the field of immunotherapy for the treatment of cancer; immunotherapy research; design of immunotherapy treatments for scientific research and medical research; genetic analyses for scientific research and medical research; Research and development services in the field of cancer immunotherapy
